Tissue Transformation Technologies Company Profile

07:07 EDT 26th September 2017 | BioPortfolio

Tissue Transformation Technologies (T-Cubed) was formed to advance the processing technologies of the perfused organ program of IIAM. While T-Cubed will continue to be affiliated with IIAM, their charter is to provide the necessary focus and resources to supply clients with enhanced products, services and new technologies as continued exploration with exciting possibilities in the processing of cells and sub-cellular fractions.


Edison Corporate Center175 May Street, Suite 600
United States of America


Phone: 732-661-2300
Fax: 732-661-2360

News Articles [1557 Associated News Articles listed on BioPortfolio]

Tissue Regenix Announces Proposed Acquisition of CellRight Technologies

Friday, July 21st 2017 at 3:07pm UTC Combination dramatically increases Tissue Regenix’s U.S. market presence, expands regenerative medicine capabilities allowing for better patient care SAN ANTONIO...

Tissue Regenix to buy CellRight Technologies

UK-based regenerative medical devices firm Tissue Regenix has agreed to acquire CellRight Technologies, a US regenerative medicine company based in San Antonio, Texas.

San Antonio’s CellRight Sells to U.K. Medical Company Tissue Regenix

San Antonio — CellRight Technologies, a maker of bone and tissue grafts derived from cadavers, has been purchased by a British company that also uses a process of removing DNA and cells from hu...

Tissue Regenix in talks to buy US rival Cellright

Regenerative medicine specialist Tissue Regenix PLC (LON:TRX) has confirmed talks to buy US rival Cellright. In a brief statement, the Leeds-based group said a temporary restraining order had been a...

Tissue Regenix to acquire US regenerative medicines firm

UK-based Tissue Regenix has announced the conditional acquisition of CellRight Technologies, a US regenerative…

CellRight scooped up by Tissue Regenix

Tissue Regenix Group PLC acquired CellRight Technologies LLC, which is developing regenerative osteoinductive bone scaffolds, for $25.9mm in cash and $4.1mm in potential revenue-based earn-outs.

TIssue Regenix resumes talks over Cellright acquisition as order lifted

Regenerative medtech Tissue Regenix PLC (LON:TRX) has resumed talks over the acquisition of US rival Cellright Technologies after a Texas court lifted its temporary restraining order. Tissue said ta...

Nanochip Turns Skin Into a Bioreactor

A nanochip that delivers genetic “cargo” to reprogram skin cells into different types of cells in vivo could one day be used to repair injured tissue or restore tissue function at the bedside, acc...

PubMed Articles [3107 Associated PubMed Articles listed on BioPortfolio]

Bacteria from the rhizosphere and tissues of As-hyperaccumulator Pteris vittata and their role in arsenic transformation.

Arsenic (As)-resistant bacteria are abundant in the rhizosphere and tissues of As-hyperaccumulator Pteris vittata. However, little is known about their roles in As transformation and As uptake in P. ...

NAD replenishment with nicotinamide mononucleotide protects blood-brain barrier integrity and attenuates delayed tPA-induced haemorrhagic transformation after cerebral ischemia.

Tissue plasminogen activator (tPA) is the only approved pharmacological therapy for acute brain ischemia; however, a major limitation of tPA is the haemorrhagic transformation followed by tPA treatmen...

Bioprinting technologies for disease modeling.

There is a great need for the development of biomimetic human tissue models that allow elucidation of the pathophysiological conditions involved in disease initiation and progression. Conventional two...

Monitoring breast cancer treatment using a Fourier transform infrared spectroscopy-based computational model.

Breast cancer affects one in four women, therefore, the search for new diagnostic technologies and therapeutic approaches is of critical importance. This involves the development of diagnostic tools t...

Typha latifolia as potential phytoremediator of 2,4-dichlorophenol: Analysis of tolerance, uptake and possible transformation processes.

2,4-Dichlorophenol (2,4-DCP) is considered a priority pollutant due to its high toxicity. Therefore, it is urgent to develop technologies for the disposal of this pollutant. Various remediation proces...

Clinical Trials [2451 Associated Clinical Trials listed on BioPortfolio]

The Influence of GVS on Mental Transformation

Corroboratory behavioral evidence showed interaction effects between vestibular stimulation and egocentric transformation. The investigators here examine in healthy participants, whether ...

Risk Assessment and Syndrome Evolution Models for Chronic Atrophic Gastritis Malignant Transformation

Chronic atrophic gastritis (CAG) is acknowledged as the precancerous stage of gastric cancer (GC). The present study aims to developed risk assessment and syndrome evolution models of CAG ...

Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients

This research study studies the combination of ibrutinib and obinutuzumab with or without the standard chemotherapy regimen of CHOP to see how well these drugs work in treating patients wi...

Study of Blinatumomab in Richter Transformation

The goal of this clinical research study is to learn if blinatumomab can help to control Richter Transformation (RT, a type of blood cancer). The safety of this drug will also be studied.

Interventional Radiology for the Treatment of Symptomatic Portal Hypertension in Patients With Cavernous Transformation of Portal Vein

To evaluate the values of portosystemic shunt and other interventional radiology approaches for treatment of symptomatic portal hypertension in patients with cavernous transformation of po...

Companies [1893 Associated Companies listed on BioPortfolio]

Tissue Transformation Technologies

Tissue Transformation Technologies (T-Cubed) was formed to advance the processing technologies of the perfused organ program of IIAM. While T-Cubed will continue to be affiliated with IIAM, their char...

BioTissue Technologies GmbH

BioTissue Technologies is a pioneer in the biotechnology field of tissue engineering. For over seven years we have been developing and producing "autologous tissue replacements" to restore missing or ...

Animal Technologies, Inc

Since 1986, Animal Technologies, Inc. has been a broad-based, major supplier of animal serum, blood, plasma, tissue, glands, and organs. Also available are custom tissue, glands and organs, human tiss...

Regeneration Technologies

Regeneration Technologies, Inc. is a leader in tissue-based innovations that are used to repair and promote the natural healing of human bone and other human tissues. RTI processes human musculoskelet...

Applied Tissue Technologies LLC

Applied Tissue Technologies LLC licenses advanced core technologies for wound healing and gene therapy. Our system for diagnosis and treatment of wounds controls the healing process and enhances wound...

More Information about "Tissue Transformation Technologies" on BioPortfolio

We have published hundreds of Tissue Transformation Technologies news stories on BioPortfolio along with dozens of Tissue Transformation Technologies Clinical Trials and PubMed Articles about Tissue Transformation Technologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tissue Transformation Technologies Companies in our database. You can also find out about relevant Tissue Transformation Technologies Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record